Eight-year-old mast cell cancer patient Rosie is now in partial remission and her largest tumor has significantly reduced in size, her owner Paul Conyngham, an AI consultant in Sydney, revealed.
A bold move to save his terminally ill dog has attracted attention from OpenAI CEO Sam Altman, who praised this incredible story on X.
Paul Conyngham used AI tools to analyze Rosie’s genetic data and worked with researchers to conduct his experiments.
With the help of AI, Paul explored emerging treatments like mRNA vaccines to find new possibilities for Rosie.
However, not all tumors responded as well as the largest one, and Rosie had to undergo another surgery, leaving uncertainty about her prognosis.
While the exact role of AI in developing the vaccine for Rosie remains unclear, experts recognize the promising potential of AI in medical research.
The use of AI in medical research streamlines the process from diagnosis to vaccine development, offering hope for both animals and humans to survive, although the risk of errors remains real.
